Bal Pharma Limited (BOM:524824)
92.65
+4.08 (4.61%)
At close: May 26, 2026
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.54 billion as of May 27, 2026. Its market cap has decreased by -4.32% in one year.
Market Cap
1.54B
Enterprise Value
3.00B
Revenue
3.09B
Ranking
n/a
PE Ratio
19.16
Stock Price
92.65
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.54B, an increase of 175.40%. That is a compound annual growth rate of 4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.48B | 26.48% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 2.07B |
| Speciality Medicines | 2.02B |
| Sanjivani Paranteral | 1.84B |
| Oxygenta Pharmaceutical | 1.83B |
| Coral Laboratories | 1.76B |
| Parnax Lab | 1.70B |
| Aayush Wellness | 1.54B |
| Lactose (India) | 1.53B |